//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
3-year interim analysis of the FIREFLEYE next trial demonstrates that aflibercept provides stable control for ROP and comparable safety to laser therapy buff.ly/syYWEED #EBNEOalerts #neoEBM #neosky
3d
Evidence-based Neonatology